Category: Finance
-
Gates Foundation Grants $50M for New Insecticides
The Innovative Vector Control Consortium (IVCC) has received $50 million from the Bill & Melinda Gates Foundation to continue work developing new insecticides for the control of insects like mosquitoes that transmit malaria, dengue, and other tropical diseases. The five year grant will support new and ongoing projects to develop new active ingredients for insecticides…
-
Life Sciences Venture Network Launches in New York
The New York Academy of Sciences plans to kick off the Life Science Angel Network (LSAN) at the academy’s lower Manhattan headquarters on Thursday 18 November. The new investment network is expected to connect scientists and entrepreneurs with funding to support commercialization of discoveries in biotechnology, medical devices, and health care informatics. The academy says…
-
Genzyme Sells Diagnostics Business to Sekisui Chemical
Genzyme Corporation, a biotechnology company in Cambridge, Massachusetts said today that it has an agreement with Sekisui Chemical Co., Ltd., which will acquire Genzyme’s diagnostic products business for $265 million in cash. Sekisui Chemical is a manufacturer of plastic materials for automotive and medical products, as well as PVC pipe systems and fabricated housing headquartered…
-
Foundation, Company Partner on Diabetes Clinical Study
The Juvenile Diabetes Research Foundation (JDRF) in New York, N.Y. and Amylin Pharmaceuticals Inc. in San Diego, California said today they entered into an agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of Amylin’s metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers…
-
Pfizer and UCSF Sign R&D Collaboration, More Planned
Pfizer Inc., the New York, N.Y. pharmaceutical manufacturer, said today it will establish a network of partnerships with academic medical centers to access the talents of university researchers. Called the Global Centers for Therapeutic Innovation, the University of California, San Francisco is the first university in Pfizer’s network. Pfizer plans to establish a presence at…
-
Report: U.S. Scientific Dominance Slipping
A study from Thomson Reuters, Global Research Report: United States, released today (12 November), found that research output from the United States has been surpassed by that of Asia and Europe. The report is based on an analysis of research papers in the most influential journals, as indexed by Thomson Reuters in the Web of…
-
Small Business Grant Awarded for Helicopter R&D
EMTEQ, an aviation engineering and avionics systems developer in New Berlin, Wisconsin, has received a Small Business Innovation Research (SBIR) grant from the U.S. Office of Naval Research for research on a lighting system for helicopter rotor blades. The award is part of the Department of Defense SBIR program, which devotes part of its R&D…
-
GE Plans $500 Million R&D Investment in China
General Electric Company plans to invest another $500 million in China for research and development, including regional R&D hubs to serve the Chinese market. GE Chairman and CEO Jeff Immelt announced the investment today, as part of a $2 billion plan that includes joint ventures in technology, energy, financial services, and transportation. Immelt (pictured left)…
-
European Venture Deals Decline, Euro Volume Up
Dow Jones VentureSource reports that venture capitalists put €916 million ($1.3 billion) into 198 deals for European companies in the third quarter in 2010, the lowest quarterly deal count for Europe since Dow Jones VentureSource began tracking the region ten years ago. Investment volume rose 6 percent from €866 million, despite the 25 percent drop…
-
Biotechs Awarded Michael J. Fox Foundation Grants
Two biotechnology companies report today awards of grants from the Michael J. Fox Foundation (MJFF). The foundation supports research on therapies for Parkinson’s disease. Adolor Corporation in Exton, Pennsylvania says it received a second round of funding by MJFF to support the development of treatments for levadopa (l-DOPA)-induced dyskinesia (LID) associated with Parkinson’s disease. The…